A mid-cap company whose market value is Rs. 8,626.24 crores, Poly Medicure Limited works in the hospital industry. Medical device manufacturer Poly Medicure Limited (PolyMed) specializes in manufacturing medical equipment. There are 5 production units for the firm in India. There are three facilities in Faridabad, one each in Jaipur and Haridwar and three abroad. Three facilities: a wholly owned subsidiary in China, a joint venture in Egypt, and a facility in Italy. The Board of Directors of the firm has declared the record date for the purpose of final dividend of 2.50 per equity share at face value 5 each on the equity shares of the company for the financial year 2021-22.
On Saturday, the Board of Directors of the company in a regulatory filing said that “In accordance with Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that the date of record has been fixed as Monday, 19th March, 2018. September, 2022 with a view to ensuring the eligibility of members for the final dividend of Rs. 2.50/- per equity share at face value 5/- on equity shares of the company for each financial year 2021-22. If the final dividend recommended by the Board of Directors is approved in the ensuing Annual General Meeting, such dividend shall be paid by the shareholders within 30 days from the date of approval in the ensuing Annual General Meeting, subject to deduction of tax at source. meeting.”
Shares of Poly Medicure Ltd closed on Friday 903.00 each, down 3.26% from previous close 933.40. share price has increased 32.599 up to the current market price as of December 2011 which has logged a multibagger return and an all-time high of 2,670.79% which represents a CAGR of around 35.48%. The stock has generated a multibagger return of 338.19% and an estimated CAGR of 34.52% over the last five years. The company has given a multibagger return of 371.44% in the last three years, but it has fallen by 5.82% in the last one year and 6.03% in 2022 in the YTD.
The stock touched a 52-week high on the NSE 1,078.00 at (29-Nov-2021) and 52-week low of At 651.10 (26-May-2022) it shows that the stock is trading up 16.23% from the high and 38.68% from the low at the current market price. For the quarter ended June 2022, the company recorded a promoter holding of 53.34%, which is a QoQ growth of 8.68% as compared to the promoter holding of 44.6% recorded in the quarter ended March. In fact, the promoter holding is much higher than its peers like Apollo Hospitals, Max Healthcare, Fortis Healthcare, Aster DM Health and Krishna Institute of Medical Sciences Ltd.
catch all business News, market news, today’s fresh news events and breaking news Updates on Live Mint. download mint news app To get daily market updates.